Basel Medical Group Ltd Ordinary Shares (BMGL) - Total Liabilities
Based on the latest financial reports, Basel Medical Group Ltd Ordinary Shares (BMGL) has total liabilities worth $11.99 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Basel Medical Group Ltd Ordinary Shares long-term investment allocation to see how much of total assets are deployed in long-term investments.
Basel Medical Group Ltd Ordinary Shares - Total Liabilities Trend (2022–2025)
This chart illustrates how Basel Medical Group Ltd Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Basel Medical Group Ltd Ordinary Shares.
Basel Medical Group Ltd Ordinary Shares Competitors by Total Liabilities
The table below lists competitors of Basel Medical Group Ltd Ordinary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ssif Broker Cl
RO:BRK
|
Romania | RON152.17 Million |
|
Phio Pharmaceuticals Corp
NASDAQ:PHIO
|
USA | $950.00K |
|
Pursuit Minerals Ltd
AU:PUR
|
Australia | AU$635.60K |
|
Fourth-Link Inc.
KQ:056730
|
Korea | ₩14.89 Billion |
|
Value8 N.V
AS:PREVA
|
Netherlands | €27.29 Million |
|
The Grob Tea Company Limited
NSE:GROBTEA
|
India | Rs332.49 Million |
|
Gaya Abadi Sempurna
JK:SLIS
|
Indonesia | Rp97.63 Billion |
|
Fingerprint Cards AB (publ)
ST:FING-B
|
Sweden | Skr32.20 Million |
Liability Composition Analysis (2022–2025)
This chart breaks down Basel Medical Group Ltd Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Basel Medical Group Ltd Ordinary Shares balance sheet independence to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.23 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.47 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.71 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Basel Medical Group Ltd Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Basel Medical Group Ltd Ordinary Shares (2022–2025)
The table below shows the annual total liabilities of Basel Medical Group Ltd Ordinary Shares from 2022 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-06-30 | $11.99 Million | +37.08% |
| 2024-06-30 | $8.75 Million | -11.57% |
| 2023-06-30 | $9.89 Million | -24.74% |
| 2022-06-30 | $13.14 Million | -- |
About Basel Medical Group Ltd Ordinary Shares
Basel Medical Group Ltd provides healthcare services in Singapore. The company offers general and subspecialized orthopedic, including trauma and sports medicine services, such as knee/hip replacements, sports medicine/surgery, spine surgery, foot/ankle surgery, and minimally invasive orthopedic procedures, as well as neurosurgical treatments. It also provides health screening services, mental he… Read more